Oncoral Pharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

Oncoral Pharma General Information

Description

Developer of a novel proprietary tablet formulation designed to treat cancer. The company's formulations are composed of irinotecan, a widely used chemotherapeutic agent with a documented effect on certain solid tumors, enabling patient to overcome important side-effects of novel tablet formulation.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Healthcare Services
Acquirer
Corporate Office
  • Energivej 42
  • 2750 Ballerup
  • Denmark

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncoral Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 14-Sep-2017 Completed Generating Revenue
2. Grant 07-Oct-2013 Completed Startup
1. Early Stage VC 25-Sep-2013 Completed Startup
To view Oncoral Pharma’s complete valuation and funding history, request access »

Oncoral Pharma Patents

Oncoral Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2973906-A1 Solid oral dosage form of irinotecan for the treatment of cancer Active 17-Jan-2014 0000000000
ES-2680444-T3 Solid oral dosage form of irinotecan for cancer treatment Active 17-Jan-2014 00000000000
US-10143657-B2 Solid oral dosage form of irinotecan for the treatment of cancer Active 17-Jan-2014 00000000000 00
US-11419825-B2 Solid oral dosage form of irinotecan for the treatment of cancer Active 17-Jan-2014 0000000000 00
US-20160331692-A1 Solid oral dosage form of irinotecan for the treatment of cancer Active 17-Jan-2014 A61K31/4745 0
To view Oncoral Pharma’s complete patent history, request access »

Oncoral Pharma Board Members (1)

Name Representing Role Since
Hans Schambye Ph.D Self Board Member 000 0000
To view Oncoral Pharma’s complete board members history, request access »

Oncoral Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncoral Pharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Capnova Venture Capital Minority 000 0000 000000 0
The Danish National Advanced Technology Foundation Limited Partner Minority 000 0000 000000 0
To view Oncoral Pharma’s complete investors history, request access »

Oncoral Pharma FAQs

  • When was Oncoral Pharma founded?

    Oncoral Pharma was founded in 2013.

  • Where is Oncoral Pharma headquartered?

    Oncoral Pharma is headquartered in Ballerup, Denmark.

  • What is the size of Oncoral Pharma?

    Oncoral Pharma has 3 total employees.

  • What industry is Oncoral Pharma in?

    Oncoral Pharma’s primary industry is Drug Discovery.

  • Is Oncoral Pharma a private or public company?

    Oncoral Pharma is a Private company.

  • What is Oncoral Pharma’s current revenue?

    The current revenue for Oncoral Pharma is 000000.

  • Who are Oncoral Pharma’s investors?

    Capnova and The Danish National Advanced Technology Foundation have invested in Oncoral Pharma.

  • When was Oncoral Pharma acquired?

    Oncoral Pharma was acquired on 14-Sep-2017.

  • Who acquired Oncoral Pharma?

    Oncoral Pharma was acquired by Ascelia Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »